Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression-Reference-Cited by-同舟云学术

Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression

Published:1993-04 Issue:1 Volume:235 Page:167-168
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Asin Karen E.,Wirtshafter David

Publisher

Elsevier BV

Subject

Pharmacology

Reference6 articles.

1. Rapid reversal of supersensitivity of denervated D1 receptors by L-dopa or a novel D1 agonist, A68930;Britton;Eur. J. Pharmacol.,1991

2. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: Behavioral effects and induction of c-fos-like immunoreactivity;Johnson;J. Pharmacol. Exp. Ther.,1992

3. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets;Kebabian;Eur. J. Pharmacol.,1992

4. Expression of the immediate-early gene c-fos in basal ganglia: Induction by dopaminergic drugs;Robertson;Can. J. Neurol. Sci.,1991

5. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion;Rouillard;Eur. J. Pharmacol.,1988

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primate;Psychopharmacology;2023-03-24

2. The Signaling and Pharmacology of the Dopamine D1 Receptor;Frontiers in Cellular Neuroscience;2022-01-17

3. Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism;Neurobiology of Disease;2021-09

4. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia;Biological Psychiatry;2017-01

5. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C;Neuropharmacology;2014-11